Search
Search
About
Log in
Join
Experiences with
Tecentriq
Posts
Communities
45 public posts
Filter results
Update
They are changing my treatment to
tecentriq
. A new drug that was cleared by the FDA in October of last year. I guess we will see what happens next.
They are changing my treatment to
tecentriq
. A new drug that was cleared by the FDA in October of last year. I guess we will see what happens next.
Dragracer
in
Lung Cancer Support
7 years ago
Advanced Prostate Cancer: Research Update
Researchers are also studying other checkpoint inhibitors, including: •Atezolizumab (
Tecentriq
) •Nivolumab (Opdivo) •Pembrolizumab (Keytruda) WebMD Feature Reviewed by Laura J. Martin, MD on December 10, 2016 Sources © 2014 WebMD, LLC.
Researchers are also studying other checkpoint inhibitors, including: •Atezolizumab (
Tecentriq
) •Nivolumab (Opdivo) •Pembrolizumab (Keytruda) WebMD Feature Reviewed by Laura J. Martin, MD on December 10, 2016 Sources © 2014 WebMD, LLC.
motosue
in
Advanced Prostate Cancer
7 years ago
New immunotherapy approved by the FDA
Late yesterday, the FDA announced that atezolizumab (
Tecentriq
) was approved for treatment of patients with lung cancer who have disease progression during or after chemo or a targeted therapy. This immunotherapy works a bit differently than other drugs and targets PD-L1.
Late yesterday, the FDA announced that atezolizumab (
Tecentriq
) was approved for treatment of patients with lung cancer who have disease progression during or after chemo or a targeted therapy. This immunotherapy works a bit differently than other drugs and targets PD-L1.
MFH_Advocate
in
Lung Cancer Support
8 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Promising news from a European oncology meeting
Some news on lung cancer treatments from the European Society for Medical Oncology (or ESMO): - A new immunotherapy (atezolizumab or
Tecentriq
) improved survival vs chemo as second-line therapy for patients with NSCLC. This drug could be FDA-approved by October 19.
Some news on lung cancer treatments from the European Society for Medical Oncology (or ESMO): - A new immunotherapy (atezolizumab or
Tecentriq
) improved survival vs chemo as second-line therapy for patients with NSCLC. This drug could be FDA-approved by October 19.
MFH_Advocate
in
Lung Cancer Support
8 years ago
The latest news on another immunotherapy
A new immunotherapy called
Tecentriq
showed positive results in a study of patients with lung cancer. This new treatment could be FDA approved for the treatment of lung cancer as early as October.
A new immunotherapy called
Tecentriq
showed positive results in a study of patients with lung cancer. This new treatment could be FDA approved for the treatment of lung cancer as early as October.
MFH_Advocate
in
Lung Cancer Support
8 years ago
1
2
3
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
10 results
SHARE Metastatic Breast Cancer
10 results
Blue Faery Liver Cancer
9 results
View top 10 communities
Sort by
Most Relevant
Newest